These findings are consistent with the results obtained by Mao et al. [23], who suggested that probiotics could enhance the anti-tumor immune response of CD8 + T cells and IFN-γ + T cells in the tumor microenvironment in patients with colorectal carcinoma. The gene discussed is CD8A; the disease is colorectal carcinoma.